The following discussion and analysis of our financial condition and results of
operations, and quantitative and qualitative disclosures about market risk
should be read in conjunction with our consolidated financial statements and the
related notes included in this Form 10-K, as well as Part II, Item 7
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" of our Form 10-K for the year ended February 1, 2019, which provides
additional information on comparisons of fiscal 2019 and 2018. It contains
forward-looking statements (which may be identified by words such as those
described in "Risk Factors-Forward-Looking Statement Risks" in Part I of this
report), including statements regarding our intent, belief, or current
expectations with respect to, among other things, trends affecting our financial
condition or results of operations; backlog; our industry; government budgets
and spending; market opportunities; the impact of competition; and the impact of
the Engility and Unisys Federal acquisitions. Such statements are not guarantees
of future performance and involve risks and uncertainties, and actual results
may differ materially from those in the forward-looking statements as a result
of various factors. Risks, uncertainties and assumptions that could cause or
contribute to these differences include those discussed below and elsewhere in
this report, particularly in "Risk Factors" in Part I of this report. Due to
such risks, uncertainties and assumptions you are cautioned not to place undue
reliance on such forward-looking statements, which speak only as of the date
hereof. We do not undertake any obligation to update these factors or to
publicly announce the results of any changes to our forward-looking statements
due to future results or developments.
We use the terms "SAIC," the "Company," "we," "us" and "our" to refer to Science
Applications International Corporation and its consolidated subsidiaries.
The Company utilizes a 52/53 week fiscal year ending on the Friday closest to
January 31, with fiscal quarters typically consisting of 13 weeks. Fiscal 2018
began on February 4, 2017 and ended on February 2, 2018, fiscal 2019 began on
February 3, 2018 and ended on February 1, 2019, and fiscal 2020 began on
February 2, 2019 and ended on January 31, 2020.
Business Overview
We are a leading technology integrator providing full life cycle services and
solutions in the technical, engineering and enterprise information technology
(IT) markets. We developed our brand by addressing our customers' mission
critical needs and solving their most complex problems for over 50 years. As one
of the largest pure-play technical service providers to the U.S. government, we
serve markets of significant scale and opportunity. Our primary customers are
the departments and agencies of the U.S. government. We serve our customers
through approximately 1,800 active contracts and task orders and employ more
than 24,000 individuals who are led by an experienced executive team of proven
industry leaders. Our long history of serving the U.S government has afforded us
the ability to develop strong and longstanding relationships with some of the
largest customers in the markets we serve. Substantially all of our revenues and
tangible long-lived assets are generated by or owned by entities located in the
United States.
Economic Opportunities, Challenges and Risks
In fiscal 2020, we generated greater than 95% of our revenues from contracts
with the U.S. government, including subcontracts on which we perform. Our
business performance is affected by the overall level of U.S. government
spending and the alignment of our offerings and capabilities with the budget
priorities of the U.S. government. Appropriations measures passed in December
2019 provide full funding for the federal government through the end of
government fiscal year (GFY) 2020. These bills are funded at increased levels
for defense and non-defense spending based on the August 2019 Bipartisan Budget
Act agreement that raises the Budget Control Act spending caps enacted in August
2011 and suspends the Federal debt ceiling until July 31, 2021.
Adverse changes in fiscal and economic conditions could materially affect our
business. Some changes that could have an adverse impact on our business include
the implementation of future spending reductions (including sequestration) and
government shutdowns.
The U.S. government has increasingly relied on contracts that are subject to a
competitive bidding process (including indefinite delivery, indefinite quantity
(IDIQ), U.S. General Services Administration (GSA) schedules and other
multi-award contracts) which has resulted in greater competition and increased
pricing pressure. We expect that a majority of the business that we seek in the
foreseeable future will be awarded through a competitive bidding process.

                                       22

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Despite the budget and competitive pressures impacting the industry, we believe
we are well positioned to protect and expand existing customer relationships and
benefit from opportunities that we have not previously pursued. Our scale, size
and prime contractor leadership position are expected to help differentiate us
from our competitors, especially on large contracts. We believe our long-term,
trusted customer relationships and deep technical expertise provide us with the
sophistication to handle highly complex mission-critical contracts. SAIC's value
proposition is found in the proven ability to serve as a trusted adviser to our
customers. In doing so, we leverage our expertise and scale to help them execute
their mission.
We succeed as a business based on the solutions we deliver, our past performance
and our ability to compete on price. Our solutions, inspired through innovation,
are based on best practices and technology transfer. Our past performance was
achieved by employee dedication and customer focus. Our current cost structure,
as well as our ongoing efforts to reduce costs by strategic sourcing and
developing repeatable offerings, is expected to allow us to compete effectively
on price in an evolving environment. Our ability to be competitive in the future
will continue to be driven by our reputation of successful program execution,
competitive cost structure and efficiencies in assigning the right people, at
the right time, in support of our contracts.
On January 14, 2019, we completed the acquisition of Engility Holdings, Inc.
(collectively with its consolidated subsidiaries, "Engility"). The acquisition
of Engility accelerates the execution of our long-term strategy to be the
premier technology integrator in the government services market and deliver
sustained profitable growth. The acquisition of Engility strengthens the
execution of our long-term strategy by: (1) combining two leading government
service providers with highly complementary capabilities, customers, and
cultures (2) accelerating both companies long-term strategies, creating
sub-segment scale in strategic business areas of national interest and (3)
enhance shareholder value through improved cash flow and margin profile driven
by cost synergies and increased growth from greater customer access with more
competitive and differentiated solutions.
On March 13, 2020, we completed the acquisition of Unisys Federal, an operating
unit within Unisys Corporation. The acquisition of Unisys Federal, in alignment
with our long-term strategy, positions SAIC as a leading government services
technology integrator in digital transformation. The acquisition of Unisys
Federal: (1) enhances SAIC's capabilities in government priority areas,
including IT modernization, cloud migration, managed services, and development,
security and operations (2) expands SAIC's portfolio of intellectual property
and technology-driven offerings that enable government-tailored,
commercial-based solutions (3) increases SAIC's access to current and new
customers with a strong pipeline of new business opportunities and (4) is highly
accretive across all key financial metrics.
See "Risk Factors" in Part I of this report for additional discussion of our
industry and regulatory environment.
Impacts of the COVID-19 Pandemic
We are monitoring the ongoing outbreak of the coronavirus disease 2019
(COVID-19) and we continue to work with our stakeholders to assess further
possible implications to our business, supply chain and customers, and to take
actions in an effort to mitigate adverse consequences. Due to the nature of our
business, we have seen minimal impacts to our operations at this time and have
developed contingency plans should the disruptions increase. We cannot predict
the impact of the COVID-19 pandemic, however the longer the duration of the
event, the more likely it is that it could have an adverse effect on our
business, financial position, results of operations and/or cash flows.
See "Risk Factors" in Part I of this report for additional discussion of the
risks associated with the COVID-19 pandemic.
Management of Operating Performance and Reporting
Our business and program management process is directed by professional managers
focused on satisfying our customers by providing high quality services in
achieving program requirements. These managers carefully monitor contract margin
performance by constantly evaluating contract risks and opportunities. Through
each contract's life cycle, program managers review performance and update
contract performance estimates to reflect their understanding of the best
information available. For performance obligations satisfied over time, updates
to estimates are recognized on inception-to-date activity, during the period of
adjustment, resulting in either a favorable or unfavorable impact to operating
income.

                                       23

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





We evaluate our results of operations by considering the drivers causing changes
in revenues, operating income and operating cash flows. Given that revenues
fluctuate on our contract portfolio over time due to contract awards and
completions, changes in customer requirements, and increases or decreases in
ordering volume of materials, we evaluate significant trends and fluctuations in
these terms. Whether performed by our employees or by our subcontractors, we
primarily provide services and, as a result, our cost of revenues are
predominantly variable. We also analyze our cost mix (labor, subcontractor or
materials) in order to understand operating margin because programs with a
higher proportion of SAIC labor are generally more profitable. Changes in costs
of revenues as a percentage of revenue other than from revenue volume or cost
mix are normally driven by fluctuations in shared or corporate costs, or
cumulative revenue adjustments due to changes in estimates.
Changes in operating cash flows are described with regard to changes in cash
generated through the delivery of services, significant drivers of fluctuations
in assets or liabilities and the impacts of changes in timing of cash receipts
or disbursements.
Results of Operations
The primary financial performance measures we use to manage our business and
monitor results of operations are revenues, operating income and cash flows from
operating activities. The following table summarizes our results of operations:
                                                                                        Year Ended
                                           January 31, 2020      Percent change      February 1, 2019      Percent change      February 2, 2018
                                                                                  (dollars in millions)
Revenues                                 $            6,379            37  %       $            4,659             5  %       $            4,454
Cost of revenues                                      5,673            35  %                    4,195             4  %                    4,043
As a percentage of revenues                            88.9 %                                    90.0 %                                    90.8 %
Selling, general and administrative
expenses                                                288            82  %                      158             2  %                      155
Acquisition and integration costs                        48           (44 )%                       86           100  %                        -
Operating income                                        370            68  %                      220           (14 )%                      256
As a percentage of revenues                             5.8 %                                     4.7 %                                     5.7 %
Net income attributable to common
stockholders                             $              226            65  %       $              137           (23 )%       $              179
Cash flows provided by operating
activities                               $              458           149  %       $              184           (15 )%       $              217


Revenues. Revenues increased $1,720 million from fiscal 2019 to fiscal 2020
primarily due to the acquisition of Engility. Adjusting for the impact of
acquired revenues, revenues contracted 1.4% due to the completion of certain
contracts, including contracts with the U.S. Marine Corps, and the effect of
acquisition related dis-synergies. These decreases were partially offset by net
increases in program volume.
Cost of Revenues. Cost of revenues increased $1,478 million from fiscal 2019 to
fiscal 2020 primarily due to the acquisition of Engility. Cost of revenues as a
percentage of revenues decreased from 90.0% in fiscal 2019 to 88.9% in fiscal
2020, primarily driven by a more profitable cost mix through higher labor
content and acquisition related cost synergies.
Selling, General and Administrative Expenses. SG&A increased $130 million from
fiscal 2019 to fiscal 2020 primarily due to the acquisition of Engility and
related intangible asset amortization ($70 million) and higher business
development costs, partially offset by acquisition related cost synergies.
Operating Income. Operating income as a percentage of revenues increased to 5.8%
for fiscal 2020, compared to 4.7% for fiscal 2019, primarily due to lower
acquisition and integration costs, a more profitable labor mix and cost
synergies, partially offset by increased intangible asset amortization.
Net Income Attributable to Common Stockholders. Net income attributable to
common stockholders increased $89 million from fiscal 2019 to fiscal 2020
primarily due to higher operating income, partially offset by higher interest
expense.

                                       24

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Cash Flows Provided by Operating Activities. Cash flows provided by operating
activities were $458 million for fiscal 2020 which represented an increase of
$274 million from fiscal 2019 primarily due to cash provided from the operating
activities of Engility, customer collections recouped from the U.S. federal
government partial shutdown that occurred in the fourth quarter of fiscal 2019,
and lower payments for acquisition and integration costs. These increases were
partially offset by higher interest payments in the current year as a result of
additional borrowings related to the acquisition near the end of fiscal 2019.
Non-GAAP Measures
Earnings before interest, taxes, depreciation and amortization (EBITDA), and
adjusted EBITDA are non-GAAP financial measures. While we believe that these
non-GAAP financial measures may be useful in evaluating our financial
information, they should be considered as supplemental in nature and not as a
substitute for financial information prepared in accordance with GAAP.
Reconciliations, definitions, and how we believe these measures are useful to
management and investors are provided below. Other companies may define similar
measures differently.
EBITDA and Adjusted EBITDA. The performance measure EBITDA is calculated by
taking net income and excluding interest expense, interest income, provision for
income taxes, and depreciation and amortization. Adjusted EBITDA is calculated
by taking EBITDA and excluding restructuring costs, and acquisition and
integration costs. Integration costs excluded are costs to integrate acquired
companies and include the costs of strategic consulting services, facility
consolidation and employee severance. The acquisition and integration costs
relate to the Company's significant acquisitions of Engility and Unisys Federal.
We began excluding restructuring costs in the third quarter of fiscal 2018 as a
result of the restructuring described in Note 5 to the Consolidated Financial
Statements. Adjusted EBITDA is a performance measure that excludes costs that we
do not consider to be indicative of our ongoing operating performance.
We believe that EBITDA and adjusted EBITDA provide management and investors with
useful information in assessing trends in our ongoing operating performance and
may provide greater visibility in understanding the long-term financial
performance of the Company.
EBITDA and adjusted EBITDA is calculated as follows:

                                                                           

Year Ended

January 31, 2020

February 1, 2019 February 2, 2018


                                                                          (in millions)
Net income                                       $             229     $             137     $             179
Interest expense                                                90                    53                    44
Interest income                                                 (4 )                  (3 )                  (1 )
Provision for income taxes                                      57                    33                    35
Depreciation and amortization                                  131                    47                    44
EBITDA                                                         503                   267                   301
EBITDA as a percentage of revenues                             7.9 %                 5.7 %                 6.8 %
Acquisition and integration costs                               48                    86                     -
Restructuring costs                                              -                     -                    13
Depreciation included in restructuring costs and
acquisition and integration costs                               (5 )                   -                    (1 )
Recovery of acquisition and integration costs(1)                (8 )                   -                     -
Adjusted EBITDA                                  $             538     $             353     $             313
Adjusted EBITDA as a percentage of revenues                    8.4 %                 7.6 %                 7.0 %


(1)  Adjustment to reflect the portion of acquisition and integration costs
     recovered through the Company's indirect rates in accordance with Cost
     Accounting Standards.



                                       25

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Adjusted EBITDA as a percentage of revenues increased to 8.4% for fiscal 2020,
compared to 7.6% for fiscal 2019, driven by a more profitable cost mix, cost
synergies related to the acquisition and higher net profit write-ups.
Other Key Performance Measures
In addition to the financial measures described above, we believe that bookings
and backlog are useful measures for management and investors to evaluate our
potential future revenues. We also consider measures such as contract types and
cost of revenues mix to be useful for management and investors to evaluate our
operating income and performance.
Net Bookings and Backlog. Net bookings represent the estimated amount of
revenues to be earned in the future from funded and negotiated unfunded contract
awards that were received during the period, net of adjustments to estimates on
previously awarded contracts. We calculate net bookings as the period's ending
backlog plus the period's revenues less the prior period's ending backlog and
initial backlog obtained through acquisitions.
Backlog represents the estimated amount of future revenues to be recognized
under negotiated contracts as work is performed. We do not include in backlog
estimates of revenues to be derived from IDIQ contracts, but rather record
backlog and bookings when task orders are awarded on these contracts. Given that
much of our revenue is derived from IDIQ contract task orders that renew
annually, bookings on these contracts tend to refresh annually as the task
orders are renewed. Additionally, we do not include in backlog contract awards
that are under protest until the protest is resolved in our favor.
We segregate our backlog into two categories as follows:
•      Funded Backlog. Funded backlog for contracts with government agencies

primarily represents estimated amounts of revenue to be earned in the

future from contracts for which funding is appropriated less revenues

previously recognized on these contracts. It does not include the unfunded

portion of contracts in which funding is incrementally appropriated or

authorized on a quarterly or annual basis by the U.S. government and other

customers even though the contract may call for performance over a number

of years. Funded backlog for contracts with non-government customers

represents the estimated value on contracts, which may cover multiple


       future years, under which we are obligated to perform, less revenues
       previously recognized on these contracts.

• Negotiated Unfunded Backlog. Negotiated unfunded backlog represents

estimated amounts of revenue to be earned in the future from negotiated


       contracts for which funding has not been appropriated or otherwise
       authorized and from unexercised priced contract options. Negotiated
       unfunded backlog does not include any estimate of future potential task

orders expected to be awarded under IDIQ, GSA Schedules or other master

agreement contract vehicles.




We expect to recognize revenue from a substantial portion of our funded backlog
within the next twelve months. However, the U.S. government can adjust the scope
of services of or cancel contracts at any time. Similarly, certain contracts
with commercial customers include provisions that allow the customer to cancel
prior to contract completion. Most of our contracts have cancellation terms that
would permit us to recover all or a portion of our incurred costs and fees
(contract profit) for work performed.
The estimated value of our total backlog as of the dates presented was:
                              January 31, 2020      February 1, 2019
                                          (in millions)
Funded backlog              $            2,569    $            2,753
Negotiated unfunded backlog             12,748                11,048
Total backlog               $           15,317    $           13,801


We had net bookings worth an estimated $7.9 billion and $4.6 billion during fiscal 2020 and fiscal 2019, respectively. Fiscal 2020 total backlog has increased from the prior year primarily due to due to several large awards received during the period from classified customers in the intelligence community, the U.S. Air Force, NASA, and other various federal government customers, as well as increased funding on existing contracts.


                                       26

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Contract Types. Our earnings and profitability may vary materially depending on
changes in the proportionate amount of revenues derived from each type of
contract. For a discussion of the types of contracts under which we generate
revenue, see "Business-Contract Types" in Part I of this report. The following
table summarizes revenues by contract type as a percentage of revenues for the
periods presented:
                                                    Year Ended
                           January 31, 2020     February 1, 2019     February 2, 2018
Cost reimbursement                       57 %                 50 %                 45 %
Time and materials (T&M)                 20 %                 23 %                 27 %
Firm-fixed price (FFP)                   23 %                 27 %                 28 %
Total                                   100 %                100 %                100 %



Our contract mix reflects an increase in cost reimbursement type contracts due
to the acquisition of Engility, which historically had a higher proportion of
cost reimbursement type contracts, and a change in contract type on a
significant contract supporting the Department of Defense.
Cost of Revenues Mix. We generate revenues by providing a customized mix of
services to our customers. The profit generated from our service contracts is
affected by the proportion of cost of revenues incurred from the efforts of our
employees (which we refer to below as labor-related cost of revenues), the
efforts of our subcontractors and the cost of materials used in the performance
of our service obligations under our contracts. Contracts performed with a
higher proportion of SAIC labor are generally more profitable. The following
table presents changes in cost mix for the periods presented:
                                                                Year Ended
                                                   January      February      February
                                                  31, 2020       1, 2019       2, 2018
                                                    (as a % of total cost of revenues)
Labor-related cost of revenues                          54 %          48 %          47 %
Subcontractor-related cost of revenues                  29 %          30 %          33 %
Supply chain materials-related cost of revenues         11 %          15 %          13 %
Other materials-related cost of revenues                 6 %           7 %  

7 %

Cost of revenues mix for fiscal 2020 reflects an increase in labor-related content primarily due to the acquisition of Engility, which historically had a higher proportion of such costs.



Liquidity and Capital Resources
As a services provider, our business generally requires minimal infrastructure
investment. We expect to fund our ongoing working capital, commitments and any
other discretionary investments with cash on hand, future operating cash flows
and, if needed, borrowings under our $400 million Revolving Credit Facility and
$300 million receivable factoring facility.
We anticipate that our future cash needs will be for working capital, capital
expenditures, and contractual and other commitments. We consider various
financial measures when we develop and update our cash deployment strategy,
which include evaluating cash provided by operating activities, free cash flow
and financial leverage. When our cash generation enables us to exceed our target
average minimum cash balance, we intend to deploy excess cash through dividends,
share repurchases, debt prepayments or strategic acquisitions.
Upon the acquisition of Engility, we drew $1.1 billion on our committed
five-year senior secured term loan facility, see Note 11 to the Consolidated
Financial Statements. The proceeds were used to repay Engility's existing credit
facility and outstanding notes. In addition, the Revolving Credit Facility
increased by an additional $200 million upon the successful completion of the
acquisition.
Upon the acquisition of Unisys Federal, we drew $0.6 billion on our incremental
senior secured Term Loan B Facility due March 2027 and issued $400 million of
Senior Notes due 2028. In addition, in February 2020 we sold $200

                                       27

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





million of accounts receivable under our receivable factoring facility.  See
Note 18 to the Consolidated Financial Statements. The proceeds were used for the
purchase of Unisys Federal.
Our ability to fund these needs will depend, in part, on our ability to generate
cash in the future, which depends on our future financial results. Our future
results are subject to general economic, financial, competitive, legislative and
regulatory factors that may be outside of our direct control. Although we
believe that the financing arrangements in place will permit us to finance our
operations on acceptable terms and conditions for at least the next year, our
future access to, and the availability of financing on acceptable terms and
conditions will be impacted by many factors (including our credit rating,
capital market liquidity and overall economic conditions). Therefore, we cannot
ensure that such financing will be available to us on acceptable terms or that
such financing will be available at all. Nevertheless, we believe that our
existing cash on hand, generation of future operating cash flows, and access to
bank financing and capital markets will provide adequate resources to fund our
short-term liquidity and long-term capital needs.
Borrowings under our Term Loan Facilities, our receivable factoring facility
and, if used in the future, our Revolving Credit Facility incur interest at a
variable rate. In accordance with our risk management objectives, we hold fixed
interest rate swap agreements to hedge the variability in interest payment cash
flows on a substantial portion of our outstanding variable rate debt. These
instruments are accounted for as cash flow hedges. Under the swap agreements, we
pay the fixed rate and the counterparties to the agreement pay a floating
interest rate.
Our Credit Facility contains customary terms and conditions including financial
covenants and covenants restricting the Company's ability to merge or
consolidate with another entity or undertake other fundamental changes, enter
into property sale and leaseback transactions, and incur liens. The Company's
dividends and share repurchases may be limited under certain leverage ratios,
and we may be required to make an annual debt prepayment based on our cash flows
from operating activities. See Note 11 of the notes to the consolidated
financial statements contained within this report for a more complete
understanding of our Credit Facility.

We currently maintain credit ratings from major U.S. rating agencies. Failure to
maintain acceptable ratings could have an adverse effect on the Company's future
cost of capital and any significant increase in the level of our borrowings
could negatively impact these ratings.
During fiscal 2020 we repurchased approximately 2.2 million shares of our common
stock for $177 million from the open market in connection with our existing
share repurchase program. Since the program's inception in December of 2013, we
have repurchased 11.8 million shares for $716 million.
Historical Cash Flow Trends
The following table summarizes our cash flows:
                                                                            

Year Ended

January 31, 2020

February 1, 2019 February 2, 2018


                                                                             (in millions)
Net cash provided by operating activities           $             458     $             184     $             217
Net cash used in investing activities                             (47 )              (1,028 )                 (22 )
Net cash (used in) provided by financing activities              (455 )                 938                  (261 )

Total (decrease) increase in cash, cash equivalents and restricted cash

                                 $             (44 )   $              94     $             (66 )


Cash Provided by Operating Activities. Refer to "Results of Operations" above
for a discussion of the changes in cash provided by operating activities between
fiscal 2020 and fiscal 2019.
Cash Used in Investing Activities. Cash used in investing activities decreased
in fiscal 2020 compared to the prior year period primarily due to cash paid for
the acquisition of Engility in the prior year, partially offset by purchases of
marketable securities.
Cash Used In/Provided by Financing Activities. Cash used in financing activities
increased in fiscal 2020 compared to the prior year period primarily due to
proceeds from borrowings in the prior year, higher share repurchases and an
increase in dividend payments to stockholders.

                                       28

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Off-Balance Sheet Arrangements
For an understanding of our obligations relating to surety bonds, see Note 16 of
the notes to the consolidated financial statements contained within this report.
Contractual Obligations
The following table summarizes, as of January 31, 2020, our obligations to make
future payments pursuant to certain contracts or arrangements and provides an
estimate of the fiscal years in which these obligations are expected to be
satisfied:
                                                        Payments Due by Fiscal Year
                                                                                                   2026 -
                                    Total          2021       2022-2023       2024-2025        Thereafter
                                                               (in millions)
Contractual obligations:
Long-term debt including
current portion(1)              $   1,941     $      70     $       215     $       672     $         984
Interest payments on long-term
debt(2)                               270            62             107              77                24
Operating lease obligations           235            41              84              53                57
Estimated purchase
obligations(3)                         94            59              19               7                 9
Other long-term liabilities(4)         84            17              49               3                15

Total contractual obligations $ 2,624 $ 249 $ 474 $ 812 $ 1,089

(1) The amounts presented are based on an anticipated loan repayment schedule.

However, we may be required to make certain mandatory prepayments based on

our level of cash flow generation and we also have the option to prepay loan

principal amounts at any time.

(2) Amounts include an estimate of future variable interest payments on the Term

Loan Facilities based on scheduled outstanding principal amounts, current

applicable margin and projected 1-month LIBOR as of January 31, 2020. The

amounts presented in this table exclude the effects of interest rate swaps

used to hedge against changes in 1-month LIBOR.

(3) Includes estimated obligations to transfer funds under legally enforceable

agreements for fixed or minimum amounts or quantities of goods or services

at fixed or minimum prices. Excludes purchase orders for services or

products to be delivered pursuant to U.S. government contracts in which we

have full recourse under normal contract termination clauses.

(4) Other long-term liabilities primarily consist of liabilities associated with

deferred compensation plan obligations, liabilities for unrecognized tax

benefits, and expected contributions to fund defined benefit plans for

fiscal 2021. Deferred compensation plan obligations have been allocated to

fiscal years based on participants' payment elections on retirement and

estimated retirement ages, but is subject to acceleration on participants'

termination of employment prior to retirement. Liabilities for unrecognized

tax benefits are allocated to the fiscal years in which the statute of

limitations is currently expected to expire. Expected contributions to fund

defined benefit plans after fiscal 2021 are not estimable at this time.




Commitments and Contingencies
We are subject to a number of reviews, investigations, claims, lawsuits and
other uncertainties related to our business. For a discussion of these items,
see Note 16 of the notes to the consolidated financial statements contained
within this report.
Critical Accounting Policies
Our discussion and analysis of our financial condition and results of operations
are based on our consolidated financial statements, which are prepared in
accordance with U.S. generally accepted accounting principles. The preparation
of these financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and the
disclosure of contingencies, as well as the reported amounts of revenues,
expenses, gains and losses during the reporting periods. Management evaluates
these estimates and assumptions on an ongoing basis. Our estimates and
assumptions have been prepared on the basis of the most current reasonably
available information and, in some cases, are our basis for making judgments
about the carrying values of assets and liabilities that are not readily
apparent from other sources. Estimates and assumptions may change in the future
as more current information is available.

                                       29

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Management believes that our critical accounting policies are those that are
both material to the presentation of our financial condition and results of
operations and require management's most difficult, subjective and complex
judgments. Typically, the circumstances that make these judgments difficult,
subjective and complex have to do with making estimates about the effect of
matters that are inherently uncertain. These policies are described below.
Revenue Recognition. We generate our revenues primarily from long-term contracts
in which we provide technical, engineering and enterprise IT services directly
for the U.S. government and as a subcontractor with other contractors engaged in
work for the U.S. government. We evaluate the nature of the contract and the
services provided when determining the accounting method utilized for each
contract. We recognize a significant portion of our revenues using a cost input
measure of progress that requires us to rely on the skill and expertise of our
engineers, program managers and business management professionals in the many
areas of cost estimation. These estimates of costs can span several years and
take into account many factors including the availability, productivity and cost
of labor, potential delays in our performance and the level of future indirect
cost allocations.
We provide for anticipated losses on long-term production type contracts and
service contracts with the U.S. government by recording an expense for the total
expected contract loss during the period when the loss is determined. Contract
costs incurred for U.S. government contracts (including allocated indirect
costs) are subject to audit and adjustment through negotiations with government
representatives. Revenues on U.S. government contracts have been recorded in
amounts that are expected to be realized on final settlement.
Many of our contracts include forms of variable consideration such as
reimbursable costs, award and incentive fees, usage-based pricing, service-level
penalties, performance bonuses, and other provisions that can either increase or
decrease the transaction price. Variable amounts generally are determined upon
our achievement of certain performance metrics, program milestones or cost
targets and may be based upon customer discretion. At contract inception, we
estimate the transaction price and may include variable consideration in the
transaction price only to the extent it is probable that a significant reversal
of cumulative revenue recognized will not occur when the uncertainty associated
with the variable consideration is resolved. When developing these estimates, we
consider the customer, contract terms, the complexity of the work and related
risks, the extent of customer discretion, historical experience and the
potential of a significant reversal of revenue.
Changes in Estimates on Contracts. Changes in estimates of revenues, cost of
revenues or profits related to performance obligations satisfied over time are
recognized in operating income in the period in which such changes are made for
the inception-to-date effect of the changes. Changes in these estimates can
routinely occur over the performance period for a variety of reasons, which
include: changes in scope; changes in cost estimates due to unanticipated cost
growth or reassessments of risks impacting costs; changes in the estimated
transaction price, such as variable amounts for incentive or award fees; and
performance being better or worse than previously estimated. In cases when total
expected costs exceed total estimated revenues for a performance obligation, the
Company recognizes the total estimated loss in the quarter identified. Total
estimated losses are inclusive of any unexercised options that are probable of
award, only if they increase the amount of the loss. Aggregate changes in
contract estimates increased operating income by $22 million for fiscal 2020,
increased operating income by $17 million for fiscal 2019 and decreased
operating income by $3 million for fiscal 2018. For additional information
related to changes in estimates on contracts, including gross favorable and
unfavorable adjustments as well as the impact to earnings per share, see Note 3
of the notes to the consolidated financial statements contained within this
report.
Business Combinations. We record all tangible and intangible assets acquired and
liabilities assumed in a business combination at fair value as of the
acquisition date, which is determined using a cost, market or income
approach. The excess amount of the aggregated purchase consideration paid over
the fair value of the net of assets acquired and liabilities assumed is recorded
as goodwill. Acquisition date fair value represents the price that would be
received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants as measured on the acquisition date.
The valuations are based on information that existed as of the acquisition date.
During the measurement period that shall not exceed one year from the
acquisition date, we may adjust provisional amounts recorded for assets acquired
and liabilities assumed to reflect new information that we have subsequently
obtained regarding facts and circumstances that existed as of the acquisition
date.

                                       30

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Acquisition-related costs that are not part of the purchase price consideration
are expensed as incurred, except for certain costs that are deferred in
connection with the issuance of debt. These costs typically include
transaction-related costs, such as finder's fees, and legal, accounting and
other professional costs.
Goodwill and Intangible Assets. Goodwill is recorded as the difference between
the aggregate consideration paid for an acquisition and the fair value of the
net tangible and intangible assets acquired and liabilities assumed. Goodwill is
not amortized, but rather tested for potential impairment annually at the
beginning of the fourth quarter, or whenever events or changes in circumstances
indicate that the carrying value may not be recoverable.
The goodwill impairment test is performed at the reporting unit level. The
Company estimates and compares the fair value of each reporting unit to its
respective carrying value including goodwill. If the fair value is less than the
carrying value, the amount of impairment expense is equal to the difference
between the reporting unit's fair value and the reporting unit's carrying value.
Determining the fair value of each reporting unit involves judgment and the use
of estimates and assumptions. We estimate the fair value of our reporting units
using either a market approach, income approach, or a combination of both. For
our annual impairment analysis, we reconcile the aggregate fair value of all of
our reporting units to our market capitalization as of the measurement date.
Under the income approach, we estimate the fair value of a reporting unit using
a multi-year discounted cash flow model that involves assumptions about
projected future revenue growth, operating margins, income tax rates, capital
expenditures, discount rate and terminal value. The discount rate is an estimate
of the cost of capital that a market participant would expect for the respective
reporting unit. The terminal value represents the present value in the last year
of the projection period of all subsequent cash flows into perpetuity.
Under the market approach, we estimate the fair value of a reporting unit based
on multiples of earnings derived from observable market data of comparable
public companies. We evaluate companies within our industry that have operations
with observable and comparable economic characteristics and are similar in
nature, scope and size to the reporting unit being compared. We analyze
historical acquisitions in our industry to estimate a control premium that we
incorporate into the fair value estimate of a reporting unit under the market
approach.
During the fourth quarter of fiscal 2020, we completed our annual goodwill
impairment testing and determined that each reporting unit's fair value
significantly exceeded its carrying value.
In addition, determining the carrying value of each reporting unit requires
judgment and involves the assignment of assets and liabilities to the reporting
units based on a systematic and rational allocation methodology. Certain assets
and liabilities may be specifically identified and assigned to a reporting unit
based on the information contained within our financial systems; whereas, other
assets and liabilities may be allocated using measurable relationships or other
basis for allocation.
Intangible assets with finite lives are amortized using the method that best
reflects how their economic benefits are utilized or, if a pattern of economic
benefits cannot be reliably determined, on a straight-line basis over their
estimated useful lives. Intangible assets with finite lives are assessed for
impairment whenever events or changes in circumstances indicate that the
carrying value may not be recoverable.
Income Taxes. Our income tax expense, deferred tax assets and liabilities, and
liabilities for unrecognized tax benefits reflect our best estimate of current
and future taxes to be paid and includes judgments related to matters for which
ultimate resolution may not become known until the final resolution of an
examination by taxing authorities or the statute of limitations lapses.
We record net deferred tax assets to the extent we believe these assets will
more likely than not be realized. In making this determination, we consider all
available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax planning
strategies and recent operating results. If we were to determine that we would
be able to realize our deferred income tax assets in the future in excess of
their net recorded amount or would no longer be able to realize our deferred
income tax assets in the future as currently recorded, we would make an
adjustment to the valuation allowance which would either decrease or increase,
respectively, the provision for income taxes.

                                       31

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





We also recognize liabilities for uncertainty in income taxes when it is more
likely than not that a tax position will not be sustained on examination and
settlement with various taxing authorities. Liabilities for any uncertainty in
income taxes are measured based on our estimate of the largest amount of benefit
that is greater than 50% likely of being realized on ultimate settlement.
The Company recognized a tax benefit of $11 million for research and development
credits as the result of a project we completed during the fourth quarter of
FY20 to improve the method by which we identify expenditures that qualify for
the research and development tax credit. We recognized $6 million in research
and development credits related to fiscal year 2016 through fiscal year 2019 and
$5 million related to the fiscal year 2020 tax year from the study. While we
expect this method to provide continued benefits in fiscal 2021, we expect our
effective tax rate to increase in relation to fiscal 2020 due to the research
and development credits in fiscal year 2021 being limited to a single tax
year. For additional information concerning the research and development tax
credit, see Note 10 of the notes to the consolidated financial statements
contained within this report.
Recently Issued But Not Yet Adopted Accounting Pronouncements
For information on recently issued but not yet adopted accounting
pronouncements, see Note 1 of the notes to the consolidated financial statements
contained within this report.
Effects of Inflation
For any of the most recent three fiscal years ended January 31, 2020, inflation
has not had a significant impact on revenues or costs. Most of our contracts are
paid in U.S. dollars and our cost to perform on these contracts are generally
paid in U.S. dollars, so inflation risk is generally limited to that which is
related to the U.S. dollar. Approximately 57% of our revenues for fiscal 2020
were derived from cost-reimbursement type contracts, which have limited
inflation risk because our contracts generally entail the provision of labor on
a reimbursable basis, and, when materials are acquired, they provide for billing
to the customer during the period in which the materials were received. Bids for
longer-term FFP and T&M contracts typically include sufficient provisions for
labor and other cost escalations to cover anticipated cost increases over the
period of performance. As a result, if we were to experience significant levels
of inflation, our revenues and costs for cost-type contracts would generally
both increase commensurate with inflation and operating income as a percentage
of total revenues would not be significantly affected. Operating income as a
percentage of total revenues would not be significantly affected for longer-term
FFP and T&M contracts to the extent that bid contract cost escalations are
sufficient to cover heightened inflation levels.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to certain market risks in the normal course of business. The
following information about our market sensitive financial instruments contains
forward-looking statements.
Foreign Currency Risk
Since the substantial majority of our business is conducted in U.S. dollars, a
10% change in any foreign currency exchange rates would not have a material
impact to our financial condition or results of operations.
Interest Rate Risk
Debt obligations. Our financial risk management objective is to reduce
variability in earnings from changes in interest rates, which we may manage
through operational means or the use of financial instruments, such as interest
rate swaps. We have approximately $1.9 billion of variable rate debt. The fair
value of our outstanding long-term debt obligations approximates its carrying
value. In connection with the issuances of our variable rate Term Loan A and
Term Loan B Facilities, we entered into fixed interest rate swap agreements,
effectively converting a substantial portion of our variable rate debt to fixed
rate debt in order to mitigate our exposure to fluctuations in interest rates.
We regularly evaluate our outstanding debt and swap agreements to meet our risk
management objective. A hypothetical 50 basis points (bps) change to interest
rates would not materially change our results of operations or cash flows. For
additional information related to our debt and interest rate swap agreements,
see Note 11 and Note 12, respectively, of the notes to the consolidated
financial statements contained in this report.

                                       32

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Derivatives. As of January 31, 2020, the fair value of our fixed interest rate
swaps was $92 million (liability). Under the swap agreements, we pay a fixed
rate and the counterparties to the agreements pay a floating interest rate based
on 1-month LIBOR. A hypothetical 50 bps change in the 1-month LIBOR curve would
change the fair value of the fixed interest rate swaps up to $29 million. Since
the interest rate swaps are accounted for as cash flow hedges, the change in
fair value is reported as a component of equity (accumulated other comprehensive
income or loss). We do not hold or issue derivative financial instruments for
trading or speculative purposes. For additional information related to
calculating the fair value of our interest rate swaps, see Note 12 of the
consolidated financial statements included in this report.
Cash equivalents. A 10% unfavorable interest rate movement for interest earned
on our cash and cash equivalents would not materially impact the value of our
cash holdings and would have a negligible impact on interest income at current
market interest rates.
Inflation Risk
We have generally been able to anticipate increases in costs when pricing our
contracts. Bids for longer-term FFP contracts typically include labor and other
cost escalations in amounts that historically have been sufficient to cover cost
increases over the period of contract performance.
Item 8. Financial Statements and Supplementary Data
See our consolidated financial statements attached hereto and listed on the
index found on page   F-1   of this report.
Item 9. Changes in and Disagreements With Accountants on Accounting and
Financial Disclosure
No information is required in response to this item.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer (our
Chief Executive Officer) and principal financial officer (our Chief Financial
Officer), has evaluated the effectiveness of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934) as of January 31, 2020, and our principal executive
officer and principal financial officer have concluded that our disclosure
controls and procedures are effective to ensure that information required to be
disclosed by us in the reports that we file or submit under the Securities
Exchange Act of 1934 is recorded, processed, summarized and reported within the
time periods specified in the rules and forms of the SEC. These disclosure
controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by us in the
reports that we file or submit under the Securities Exchange Act of 1934 is
accumulated and communicated to our management, including our principal
executive officer and our principal financial officer, as appropriate to allow
timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting
during the fourth quarter of fiscal 2020 that materially affected, or are likely
to materially affect, our internal control over financial reporting.
Management's Report On Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal
control over financial reporting. Internal control over financial reporting is a
process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP.

                                       33

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION





Internal control over financial reporting includes those policies and procedures
that (i) pertain to the maintenance of records that, in reasonable detail,
completely, accurately and fairly reflect the transactions and dispositions of
our assets; (ii) provide reasonable assurance that transactions are recorded as
necessary to permit preparation of the financial statements in accordance with
GAAP; (iii) provide reasonable assurance that our receipts and expenditures are
made only in accordance with the authorization of our management and directors;
and (iv) provide reasonable assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of assets that could have a
material effect on the consolidated financial statements. Internal control over
financial reporting includes the controls themselves, monitoring and internal
auditing practices and actions taken to correct deficiencies as identified.
Our management, with the participation of the Chief Executive Officer and Chief
Financial Officer, has evaluated the effectiveness of our internal control over
financial reporting as of January 31, 2020 based on the framework established in
the 2013 Internal Control - Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission. Our management has assessed
in its evaluation the effectiveness of our internal control over financial
reporting as of January 31, 2020 and has concluded that our internal control
over financial reporting was effective.
Ernst & Young LLP, an independent registered public accounting firm, audited our
consolidated financial statements included in this report and our internal
control over financial reporting, and the firm's report on our internal control
over financial reporting are set forth below this report.
Although our management, including the Chief Executive Officer and the Chief
Financial Officer, is responsible for establishing and maintaining adequate
internal control over financial reporting, because of inherent limitations, our
management does not expect that our internal controls over financial reporting
will prevent or detect all errors and all fraud. Also, projections of any
evaluation of effectiveness in such assessment to future periods are subject to
the risk that controls may be inadequate because of changes in conditions or
that the degree of compliance with the policies or procedures may deteriorate.


                                       34

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors and Stockholders of
Science Applications International Corporation
Opinion on Internal Control Over Financial Reporting
We have audited Science Applications International Corporation's internal
control over financial reporting as of January 31, 2020, based on criteria
established in Internal Control - Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (2013 framework) (the
COSO criteria). In our opinion, Science Applications International Corporation
(the Company) maintained, in all material respects, effective internal control
over financial reporting as of January 31, 2020, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), the consolidated balance
sheets of the Company as of January 31, 2020 and February 1, 2019, the related
consolidated statements of income, comprehensive income, equity, and cash flows
for each of the two years in the period ended January 31, 2020, and the related
notes and our report dated March 26, 2020 expressed an unqualified opinion
thereon.
Basis for Opinion
The Company's management is responsible for maintaining effective internal
control over financial reporting and for its assessment of the effectiveness of
internal control over financial reporting included in the accompanying
Management's Report on Internal Control Over Financial Reporting. Our
responsibility is to express an opinion on the Company's internal control over
financial reporting based on our audit. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable
assurance about whether effective internal control over financial reporting was
maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial
reporting, assessing the risk that a material weakness exists, testing and
evaluating the design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we considered
necessary in the circumstances. We believe that our audit provides a reasonable
basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company's internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles. A company's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company's
assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Tysons, Virginia
March 26, 2020


                                       35

--------------------------------------------------------------------------------

Table of Contents

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

© Edgar Online, source Glimpses